New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement (2020)
- Authors:
- USP affiliated authors: FARIAS, KELEN CRISTINA RIBEIRO MALMEGRIM DE - FCFRP ; RODRIGUES, MARIA CAROLINA DE OLIVEIRA - FMRP
- Unidades: FCFRP; FMRP
- DOI: 10.3389/978-2-88963-472-9
- Subjects: AUTOIMUNIDADE; CÉLULAS VEGETAIS; TRANSPLANTE DE ÓRGÃOS; BIOMARCADORES; DIABETES MELLITUS; TRANSPLANTE AUTÓLOGO; IMUNOSSUPRESSÃO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher: Frontiers Media
- Publisher place: Lausanne
- Date published: 2020
- Source:
- Título: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?
- Volume/Número/Paginação/Ano: 133 p
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
COURI, Carlos Eduardo Barra e FARIAS, Kelen Cristina Ribeiro Malmegrim de e RODRIGUES, Maria Carolina de Oliveira. New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement. Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Tradução . Lausanne: Frontiers Media, 2020. . Disponível em: https://doi.org/10.3389/978-2-88963-472-9. Acesso em: 31 mar. 2026. -
APA
Couri, C. E. B., Farias, K. C. R. M. de, & Rodrigues, M. C. de O. (2020). New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement. In Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?. Lausanne: Frontiers Media. doi:10.3389/978-2-88963-472-9 -
NLM
Couri CEB, Farias KCRM de, Rodrigues MC de O. New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement [Internet]. In: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Lausanne: Frontiers Media; 2020. [citado 2026 mar. 31 ] Available from: https://doi.org/10.3389/978-2-88963-472-9 -
Vancouver
Couri CEB, Farias KCRM de, Rodrigues MC de O. New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement [Internet]. In: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Lausanne: Frontiers Media; 2020. [citado 2026 mar. 31 ] Available from: https://doi.org/10.3389/978-2-88963-472-9 - Editorial: immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?
- Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: Where do we stand? Volume II
- Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: where do we stand?
- Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?
- Lower Insulin-Dose Adjusted A1c (IDAA1c) is associated with less complications in individuals with type 1 diabetes treated with hematopoetic stem-cell transplantation and conventional therapy
- Teplizumab in relatives at risk for type 1 diabetes. [Carta]
- Autologous hematopoietic stem cell transplantation for autoimmune diseases: from mechanistic insights to biomarkers
- CMV-specific clones may lead to reduced TCR diversity and relapse in systemic sclerosis patients treated with AHSCT [Carta]
- Monitoramento imunológico após transplante de células-tronco hematopoiéticas: identificação de biomarcadores de resposta ao tratamento
- Thymus rejuvenation after autologous hematopoietic stem cell transplantation in patients with autoimmune diseases
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
